J. Scott Wolchko, President and CEO at FATE THERAPEUTICS INC (FATE), sold 39,900 shares at $91.77 ($3.7M) on 2020-12-17, disclosed to the SEC on 2020-12-18.
Open-market sale of $3.7M FATE by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.98 | 3,168 | $288K | 7.9% |
| 2 | $90.98 | 3,168 | $288K | 7.9% |
| 3 | $91.77 | 13,936 | $1.3M | 34.9% |
| 4 | $91.77 | 13,936 | $1.3M | 34.9% |
| 5 | $92.94 | 2,796 | $260K | 7.1% |
| 6 | $92.94 | 2,796 |
| $260K |
| 7.1% |
| 7 | $93.44 | 100 | $9K | 0.3% |
| Total | $91.81 avg | 39,900 | $3.7M | 100% |
| Filing → |
| FATE | SELL | 2022-07-25 | $2.4M | — | Filing → |
| FATE | SELL | 2022-04-25 | $2.6M | — | Filing → |
| FATE | SELL | 2022-01-24 | $2.0M | — | Filing → |